SLC34A2 and cancer: Rebmab200 as well as MX35 did not bind to a series of cancer cell lines derived from cervix, prostate, colon, bladder, lung, stomach or melanoma, or to a panel of 8 normal cell lines derived from ovary, kidney, lung or retina, most of them known not to express NaPi2b.